| scholarly article | Q13442814 |
| P50 | author | Barton Haynes | Q4865631 |
| Michael P. Busch | Q6833284 | ||
| Sallie R Permar | Q87955622 | ||
| John C Tilton | Q87983772 | ||
| Michael R. Betts | Q88295419 | ||
| Shilpa Iyer | Q91778068 | ||
| John C Kappes | Q92482518 | ||
| Erica H Parrish | Q114423041 | ||
| Bhavna Hora | Q114512865 | ||
| Jennifer Hopper | Q114512867 | ||
| Haitao Ding | Q114512868 | ||
| Tatenda Mahlokozera | Q114512869 | ||
| Beatrice H. Hahn | Q55293537 | ||
| Nicholas F Parrish | Q56771203 | ||
| Jesus F Salazar-Gonzalez | Q57415418 | ||
| David C. Montefiori | Q63302725 | ||
| George M. Shaw | Q78514357 | ||
| Christina Ochsenbauer | Q86991008 | ||
| Craig B Wilen | Q38590407 | ||
| P2093 | author name string | Feng Gao | |
| Marion Vermeulen | |||
| Amit Kumar | |||
| Jennifer M Pfaff | |||
| Robert W Doms | |||
| Julie M Decker | |||
| Maria G Salazar | |||
| Anna Berg | |||
| Lauren B Banks | |||
| Sally Yuan | |||
| Charl Coleman | |||
| P2860 | cites work | Genotypic and phenotypic characterization of HIV-1 patients with primary infection | Q22242245 |
| CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract | Q22242965 | ||
| HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cells | Q22251066 | ||
| CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice | Q24286950 | ||
| DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans | Q24601035 | ||
| HIV-1 envelope, integrins and co-receptor use in mucosal transmission of HIV | Q27497560 | ||
| New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0 | Q27860476 | ||
| A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors | Q28118386 | ||
| Two subsets of memory T lymphocytes with distinct homing potentials and effector functions | Q28146072 | ||
| CCR5 antagonists: comparison of efficacy, side effects, pharmacokinetics and interactions--review of the literature | Q28253064 | ||
| Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target | Q29547347 | ||
| Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection | Q29614956 | ||
| Central memory and effector memory T cell subsets: function, generation, and maintenance | Q29615097 | ||
| HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 | Q29616094 | ||
| Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody | Q29618366 | ||
| Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection | Q29619510 | ||
| Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1 | Q29619511 | ||
| HIV-1 envelope subregion length variation during disease progression | Q30397933 | ||
| Characterization of a human cervical CD4+ T cell subset coexpressing multiple markers of HIV susceptibility | Q30408905 | ||
| Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1 | Q33402461 | ||
| High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men. | Q33582135 | ||
| A rev1-vpu polymorphism unique to HIV-1 subtype A and C strains impairs envelope glycoprotein expression from rev-vpu-env cassettes and reduces virion infectivity in pseudotyping assays | Q33653774 | ||
| Rapid dissociation of HIV-1 from cultured cells severely limits infectivity assays, causes the inactivation ascribed to entry inhibitors, and masks the inherently high level of infectivity of virions | Q33676520 | ||
| Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals | Q33734957 | ||
| Donor and recipient envs from heterosexual human immunodeficiency virus subtype C transmission pairs require high receptor levels for entry | Q33769382 | ||
| Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B. | Q33780595 | ||
| Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels | Q33780649 | ||
| HIV type 1 from a patient with baseline resistance to CCR5 antagonists uses drug-bound receptor for entry | Q33807529 | ||
| The genotype of early-transmitting HIV gp120s promotes α (4) β(7)-reactivity, revealing α (4) β(7) +/CD4+ T cells as key targets in mucosal transmission | Q33839456 | ||
| DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus | Q33840771 | ||
| Wide variation in the multiplicity of HIV-1 infection among injection drug users | Q33877419 | ||
| Distribution of beta 7 integrins in human intestinal mucosa and organized gut-associated lymphoid tissue. | Q52046228 | ||
| Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. | Q55487007 | ||
| Regulation of T cell proliferation by anti-CD49d and anti-CD29 monoclonal antibodies | Q67543564 | ||
| Transmission of the X4 phenotype of HIV-1: is there evidence against the "random transmission" hypothesis? | Q82838801 | ||
| HIV infection of the genital mucosa in women. | Q37370910 | ||
| A quantitative affinity-profiling system that reveals distinct CD4/CCR5 usage patterns among human immunodeficiency virus type 1 and simian immunodeficiency virus strains | Q37410812 | ||
| The integrin alpha4beta7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1. | Q37428017 | ||
| Envelope proteins from clinical isolates of human immunodeficiency virus type 1 that are refractory to neutralization by soluble CD4 possess high affinity for the CD4 receptor | Q37588188 | ||
| Establishment of a new system for determination of coreceptor usages of HIV based on the human glioma NP-2 cell line | Q38324749 | ||
| Novel single-cell-level phenotypic assay for residual drug susceptibility and reduced replication capacity of drug-resistant human immunodeficiency virus type 1. | Q38449098 | ||
| Primary infection by a human immunodeficiency virus with atypical coreceptor tropism | Q38631923 | ||
| Immature dendritic cells selectively replicate macrophagetropic (M-tropic) human immunodeficiency virus type 1, while mature cells efficiently transmit both M- and T-tropic virus to T cells. | Q39031170 | ||
| Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding | Q39539552 | ||
| Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene | Q41699910 | ||
| A monoclonal antibody to VLA-4 alpha-chain (CDw49d) induces homotypic lymphocyte aggregation | Q43504394 | ||
| Rapid generation of sequence variation during primary HIV-1 infection. | Q43810228 | ||
| Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants | Q45867857 | ||
| HIV-1 genomic RNA diversification following sexual and parenteral virus transmission | Q45873185 | ||
| Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection. | Q46013897 | ||
| Evaluation of the anti-HIV activity of natalizumab, an antibody against integrin alpha4. | Q46180976 | ||
| Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission | Q47878972 | ||
| Presence of CXCR4-using HIV-1 in patients with recently diagnosed infection: correlates and evidence for transmission. | Q49040190 | ||
| HIV-1 resistance to CCR5 antagonists associated with highly efficient use of CCR5 and altered tropism on primary CD4+ T cells | Q33990552 | ||
| The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade. | Q33999756 | ||
| A signature in HIV-1 envelope leader peptide associated with transition from acute to chronic infection impacts envelope processing and infectivity | Q34005516 | ||
| Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infections | Q34042642 | ||
| HIV-1 replication in the central nervous system occurs in two distinct cell types. | Q34050421 | ||
| Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection | Q34228730 | ||
| Lymphocyte activation antigens. I. A monoclonal antibody, anti-Act I, defines a new late lymphocyte activation antigen | Q34245173 | ||
| Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120. | Q34428738 | ||
| Origin and evolution of HIV-1 in breast milk determined by single-genome amplification and sequencing | Q34742873 | ||
| Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity | Q35101464 | ||
| Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa | Q35140032 | ||
| HIV-specific functional antibody responses in breast milk mirror those in plasma and are primarily mediated by IgG antibodies | Q35192641 | ||
| Phenotypic and immunologic comparison of clade B transmitted/founder and chronic HIV-1 envelope glycoproteins | Q35192915 | ||
| Role of donor genital tract HIV-1 diversity in the transmission bottleneck | Q35558621 | ||
| Characterization of a thymus-tropic HIV-1 isolate from a rapid progressor: role of the envelope | Q35598496 | ||
| Topographic distribution of homing receptors on B and T cells in human gut-associated lymphoid tissue: relation of L-selectin and integrin alpha 4 beta 7 to naive and memory phenotypes | Q35765315 | ||
| Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry | Q35784750 | ||
| Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages | Q35826158 | ||
| The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes | Q36028490 | ||
| Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages | Q36340560 | ||
| Infection of monocyte-derived macrophages with human immunodeficiency virus type 1 (HIV-1). Monocyte-tropic and lymphocyte-tropic strains of HIV-1 show distinctive patterns of replication in a panel of cell types | Q36356836 | ||
| CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro | Q36377185 | ||
| Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing | Q36540055 | ||
| Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity | Q36873079 | ||
| Blocking of α4β7 gut-homing integrin during acute infection leads to decreased plasma and gastrointestinal tissue viral loads in simian immunodeficiency virus-infected rhesus macaques | Q36952767 | ||
| Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants | Q37145228 | ||
| Development of a quasispecies of human immunodeficiency virus type 1 in vivo | Q37146859 | ||
| Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease | Q37273122 | ||
| Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection | Q37273158 | ||
| The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection | Q37273195 | ||
| Heterosexual transmission of human immunodeficiency virus type 1 subtype C: Macrophage tropism, alternative coreceptor use, and the molecular anatomy of CCR5 utilization. | Q37275049 | ||
| Human immunodeficiency virus type 1 V1-to-V5 envelope variants from the chronic phase of infection use CCR5 and fuse more efficiently than those from early after infection. | Q37356028 | ||
| Selection of HIV variants with signature genotypic characteristics during heterosexual transmission | Q37370674 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P921 | main subject | HIV | Q15787 |
| HIV transmission | Q49029021 | ||
| P304 | page(s) | e1002686 | |
| P577 | publication date | 2012-05-31 | |
| P1433 | published in | PLOS Pathogens | Q283209 |
| P1476 | title | Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7 | |
| P478 | volume | 8 |
| Q27313287 | A Small Molecule, Which Competes with MAdCAM-1, Activates Integrin α4β7 and Fails to Prevent Mucosal Transmission of SHIV-SF162P3 |
| Q37336462 | A single amino acid mutation in the envelope cytoplasmic tail restores the ability of an attenuated simian immunodeficiency virus mutant to deplete mucosal CD4+ T cells |
| Q34562259 | Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trial |
| Q36110367 | Analysis of Viral Diversity in Relation to the Recency of HIV-1C Infection in Botswana |
| Q38926812 | Binding of HIV-1 virions to α4β 7 expressing cells and impact of antagonizing α4β 7 on HIV-1 infection of primary CD4+ T cells |
| Q28082862 | Bottlenecks in HIV-1 transmission: insights from the study of founder viruses |
| Q28657772 | Cellular superspreaders: an epidemiological perspective on HIV infection inside the body |
| Q34620235 | Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users |
| Q36978861 | Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design |
| Q35219829 | Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection |
| Q57796335 | Completeness of HIV-1 Envelope Glycan Shield at Transmission Determines Neutralization Breadth |
| Q39108779 | Complex immune correlates of protection in HIV-1 vaccine efficacy trials |
| Q28535848 | Construction and characterization of highly infectious full-length molecular clones of a HIV-1 CRF07_BC isolate from Xinjiang, China |
| Q34270309 | Cryptic determinant of α4β7 binding in the V2 loop of HIV-1 gp120. |
| Q91983265 | Delayed vaginal SHIV infection in VRC01 and anti-α4β7 treated rhesus macaques |
| Q36298503 | Delineating CD4 dependency of HIV-1: Adaptation to infect low level CD4 expressing target cells widens cellular tropism but severely impacts on envelope functionality. |
| Q37252894 | Derivation and Characterization of Pathogenic Transmitted/Founder Molecular Clones from Simian Immunodeficiency Virus SIVsmE660 and SIVmac251 following Mucosal Infection |
| Q92794867 | Development of a Versatile, Near Full Genome Amplification and Sequencing Approach for a Broad Variety of HIV-1 Group M Variants |
| Q37042563 | Development of prophylactic vaccines against HIV-1. |
| Q28551914 | Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus |
| Q36277153 | Differentiating founder and chronic HIV envelope sequences. |
| Q34503200 | Distinct HIV-1 entry phenotypes are associated with transmission, subtype specificity, and resistance to broadly neutralizing antibodies |
| Q37238727 | Early infection HIV-1 envelope V1-V2 genotypes do not enhance binding or replication in cells expressing high levels of α4β7 integrin |
| Q36785795 | Efficient single tobamoviral vector-based bioproduction of broadly neutralizing anti-HIV-1 monoclonal antibody VRC01 in Nicotiana benthamiana plants and utility of VRC01 in combination microbicides |
| Q37547162 | Enhanced fusion and virion incorporation for HIV-1 subtype C envelope glycoproteins with compact V1/V2 domains |
| Q42206820 | Envelope glycoprotein binding to the integrin α4β7 is not a general property of most HIV-1 strains |
| Q34907398 | Epitope mapping of conformational V2-specific anti-HIV human monoclonal antibodies reveals an immunodominant site in V2. |
| Q40080908 | Extracellular Matrix Proteins Mediate HIV-1 gp120 Interactions with α4β7. |
| Q27681527 | Functional Implications of the Binding Mode of a Human Conformation-Dependent V2 Monoclonal Antibody against HIV |
| Q38910936 | Functional attributes of evolutionary conserved Arg45 of Wolbachia (Brugia malayi) translation initiation factor-1. |
| Q36945699 | Future of phylogeny in HIV prevention |
| Q35115599 | Generation and evaluation of clade C simian-human immunodeficiency virus challenge stocks |
| Q37460075 | Genotypic and phenotypic heterogeneity in the U3R region of HIV type 1 subtype C. |
| Q40174150 | Glycosylation and oligomeric state of envelope protein might influence HIV-1 virion capture by α4β7 integrin. |
| Q36356350 | Good CoP, bad CoP? Interrogating the immune responses to primate lentiviral vaccines |
| Q36269097 | HIV transmission biology: translation for HIV prevention |
| Q93038056 | HIV vaccine delayed boosting increases Env variable region 2-specific antibody effector functions |
| Q35067233 | HIV-1 Vpr accelerates viral replication during acute infection by exploitation of proliferating CD4+ T cells in vivo |
| Q36997294 | HIV-1 Vpu Mediates HLA-C Downregulation |
| Q36827382 | HIV-1 conserved-element vaccines: relationship between sequence conservation and replicative capacity |
| Q37444204 | HIV-1 envelope replication and α4β7 utilization among newly infected subjects and their corresponding heterosexual partners |
| Q35196509 | HIV-1 target cells in the CNS. |
| Q30355260 | HIV-1 variable loop 2 and its importance in HIV-1 infection and vaccine development |
| Q42206891 | HIV/AIDS. A fitness bottleneck in HIV-1 transmission |
| Q47555873 | HLA Class I Downregulation by HIV-1 Variants from Subtype C Transmission Pairs |
| Q56909688 | HLA-C downregulation by HIV-1 adapts to host HLA genotype |
| Q36827377 | Heterogeneity in neutralization sensitivities of viruses comprising the simian immunodeficiency virus SIVsmE660 isolate and vaccine challenge stock |
| Q35778333 | Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-α Resistance |
| Q35857404 | Identification of New Regions in HIV-1 gp120 Variable 2 and 3 Loops that Bind to α4β7 Integrin Receptor |
| Q39108028 | Identification of preferential CD4+ T-cell targets for HIV infection in the cervix. |
| Q26778001 | Identifying Recent HIV Infections: From Serological Assays to Genomics |
| Q34791232 | Infection of monkeys by simian-human immunodeficiency viruses with transmitted/founder clade C HIV-1 envelopes |
| Q35855028 | Integrin α4β7 Expression Increases HIV Susceptibility in Activated Cervical CD4+ T Cells by an HIV Attachment-Independent Mechanism |
| Q38860309 | Loss of a conserved N-linked glycosylation site in the simian immunodeficiency virus envelope glycoprotein V2 region enhances macrophage tropism by increasing CD4-independent cell-to-cell transmission |
| Q59358396 | Marginal Effects of Systemic CCR5 Blockade with Maraviroc on Oral Simian Immunodeficiency Virus Transmission to Infant Macaques |
| Q36532973 | Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones |
| Q37247492 | Molecular mechanisms of HIV type 1 prophylaxis failure revealed by single-genome sequencing |
| Q37434997 | Naturally Occurring Fc-Dependent Antibody From HIV-Seronegative Individuals Promotes HIV-Induced IFN-α Production |
| Q92239576 | Negative and Positive Selection Pressure During Sexual Transmission of Transmitted Founder HIV-1 |
| Q41144784 | Optimized Replicating Renilla Luciferase Reporter HIV-1 Utilizing Novel Internal Ribosome Entry Site Elements for Native Nef Expression and Function |
| Q34309493 | Partial rescue of V1V2 mutant infectivity by HIV-1 cell-cell transmission supports the domain's exceptional capacity for sequence variation |
| Q34336058 | Phenotypic properties of transmitted founder HIV-1 |
| Q37206422 | Phylogenetic inferences on HIV-1 transmission: implications for the design of prevention and treatment interventions |
| Q37062259 | Platelet Factor 4 Inhibits and Enhances HIV-1 Infection in a Concentration-Dependent Manner by Modulating Viral Attachment |
| Q36588632 | Postnatally-transmitted HIV-1 Envelope variants have similar neutralization-sensitivity and function to that of nontransmitted breast milk variants |
| Q33638320 | Predicting HIV-1 transmission and antibody neutralization efficacy in vivo from stoichiometric parameters. |
| Q33924420 | Quantitative phosphoproteomics reveals extensive cellular reprogramming during HIV-1 entry |
| Q38899458 | R5 Macrophage-Tropic HIV-1 in the Male Genital Tract |
| Q37612507 | Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness |
| Q57751823 | Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to α4β7 |
| Q34721189 | Selection of unadapted, pathogenic SHIVs encoding newly transmitted HIV-1 envelope proteins |
| Q64979797 | Selective use of primate CD4 receptors by HIV-1. |
| Q37429714 | Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection. |
| Q35672336 | South African HIV-1 subtype C transmitted variants with a specific V2 motif show higher dependence on α4β7 for replication |
| Q40946143 | Targeting and role of α4β7 integrin in the pathophysiology of IBD and HIV infection |
| Q42314454 | The HIV-1 transmission bottleneck |
| Q52686548 | The Role of Integrin α4β7 in HIV Pathogenesis and Treatment. |
| Q34303849 | The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120. |
| Q30152923 | The V1V2 Region of HIV-1 gp120 Forms a Five-Stranded Beta Barrel |
| Q37204158 | The majority of HIV type 1 DNA in circulating CD4+ T lymphocytes is present in non-gut-homing resting memory CD4+ T cells |
| Q38079234 | The puzzling role of CXCR4 in human immunodeficiency virus infection. |
| Q42572387 | Topological analysis of HIV-1 glycoproteins expressed in situ on virus surfaces reveals tighter packing but greater conformational flexibility than for soluble gp120. |
| Q37233074 | Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs |
| Q37252583 | Transient compartmentalization of simian immunodeficiency virus variants in the breast milk of african green monkeys |
| Q36607127 | Transmitted/founder and chronic HIV-1 envelope proteins are distinguished by differential utilization of CCR5. |
| Q34433975 | Transmitted/founder simian immunodeficiency virus envelope sequences in vesicular stomatitis and Semliki forest virus vector immunized rhesus macaques |
| Q89957144 | Understanding the mechanisms driving the spread of subtype C HIV-1 |
| Q53705746 | Unique Phenotypic Characteristics of Recently Transmitted HIV-1 Subtype C Envelope Glycoprotein gp120: Use of CXCR6 Coreceptor by Transmitted Founder Viruses. |
| Q37395749 | Use of Dried Blood Spots to Elucidate Full-Length Transmitted/Founder HIV-1 Genomes |
| Q34059103 | Vaccine-induced HIV-1 envelope gp120 constant region 1-specific antibodies expose a CD4-inducible epitope and block the interaction of HIV-1 gp140 with galactosylceramide |
| Q34402934 | Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection |
| Q39400038 | Virus-Host Gene Interactions Define HIV-1 Disease Progression. |
| Q38936957 | Vpx complementation of 'non-macrophage tropic' R5 viruses reveals robust entry of infectious HIV-1 cores into macrophages. |
Search more.